Cargando…
Chronic Obstructive Pulmonary Disease in Sweden: An intersectional multilevel analysis of individual heterogeneity and discriminatory accuracy
Socioeconomic, ethnic and gender disparities in Chronic Obstructive Pulmonary Disease (COPD) risk are well established but no studies have applied multilevel analysis of individual heterogeneity and discriminatory accuracy (MAIHDA) within an intersectional framework to study this outcome. We study i...
Autores principales: | Axelsson Fisk, Sten, Mulinari, Shai, Wemrell, Maria, Leckie, George, Perez Vicente, Raquel, Merlo, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976844/ https://www.ncbi.nlm.nih.gov/pubmed/29854918 http://dx.doi.org/10.1016/j.ssmph.2018.03.005 |
Ejemplares similares
-
Antidepressant use in Sweden: an intersectional multilevel analysis
of individual heterogeneity and discriminatory accuracy (MAIHDA)
por: Ljungman, Hanna, et al.
Publicado: (2021) -
Population heterogeneity in associations between hormonal contraception and antidepressant use in Sweden: a prospective cohort study applying intersectional multilevel analysis of individual heterogeneity and discriminatory accuracy (MAIHDA)
por: Zettermark, Sofia, et al.
Publicado: (2021) -
Socioeconomic differences in body mass index in Spain: An intersectional multilevel analysis of individual heterogeneity and discriminatory accuracy
por: Hernández-Yumar, Aránzazu, et al.
Publicado: (2018) -
Geographical and sociodemographic differences in discontinuation of medication for Chronic Obstructive Pulmonary Disease – A Cross-Classified Multilevel Analysis of Individual Heterogeneity and Discriminatory Accuracy (MAIHDA)
por: Khalaf, Kani, et al.
Publicado: (2020) -
Socio-economic disparities in the dispensation of antibiotics in
Sweden 2016–2017: An intersectional analysis of individual heterogeneity and
discriminatory accuracy
por: Wemrell, Maria, et al.
Publicado: (2021)